Literature DB >> 31388757

[Unmet research and developmental needs in ophthalmology : A consensus-based road map of the European Vision Institute for 2019-2025].

C Cursiefen1,2, F Cordeiro3, J Cunha-Vaz4,5, T Wheeler-Schilling6, H P N Scholl7,8,9.   

Abstract

PURPOSE: To define unmet needs in ophthalmology which can realistically be addressed in the next years (2019-2025) and to describe potential avenues for research to address these challenges.
METHODS: Outcomes of a consensus process within the European Vision Institute (EVI, Brussels) are outlined. Disease areas which are discussed comprise glaucoma, retinal dystrophies, diabetic retinopathy, dry eye disease, corneal diseases, cataract and refractive surgery.
RESULTS: Unmet needs in the mentioned disease areas are discussed and realistically achievable research projects outlined.
CONCLUSION: Considerable progress can be made in the field of ophthalmology and patient-relevant outcomes in the near future.

Entities:  

Keywords:  Forthcoming challenges; Ophthalmology; Research; Research and developmental needs; Road map

Mesh:

Year:  2019        PMID: 31388757     DOI: 10.1007/s00347-019-00947-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  65 in total

1.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Lloyd Paul Aiello; Roy W Beck; Neil M Bressler; Susan B Bressler; Allison R Edwards; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Kellee M Miller; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2010-04-28       Impact factor: 12.079

2.  Cell types, circuits, computation.

Authors:  Rava Azeredo da Silveira; Botond Roska
Journal:  Curr Opin Neurobiol       Date:  2011-06-09       Impact factor: 6.627

3.  Limbal stem-cell therapy and long-term corneal regeneration.

Authors:  Paolo Rama; Stanislav Matuska; Giorgio Paganoni; Alessandra Spinelli; Michele De Luca; Graziella Pellegrini
Journal:  N Engl J Med       Date:  2010-06-23       Impact factor: 91.245

4.  Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy.

Authors:  In Kyung Oh; Seong-Woo Kim; Jaeryung Oh; Tae Soo Lee; Kuhl Huh
Journal:  Curr Eye Res       Date:  2010-12       Impact factor: 2.424

5.  Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable.

Authors:  Claus Cursiefen; Joseph Colin; Reza Dana; Manuel Diaz-Llopis; Lana A Faraj; Salvador Garcia-Delpech; Gerd Geerling; Francis W Price; Lies Remeijer; Barry T Rouse; Berthold Seitz; Patricia Udaondo; Daniel Meller; Harminder Dua
Journal:  Br J Ophthalmol       Date:  2011-06-28       Impact factor: 4.638

6.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

7.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

Review 8.  Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.

Authors:  José Cunha-Vaz; Rui Bernardes
Journal:  Prog Retin Eye Res       Date:  2004-12-16       Impact factor: 21.198

9.  Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.

Authors:  Tina Dietrich; Felix Bock; Don Yuen; Deniz Hos; Björn O Bachmann; Grit Zahn; Stanley Wiegand; Lu Chen; Claus Cursiefen
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

10.  Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.

Authors:  Takeru Yoshimura; Koh-hei Sonoda; Mika Sugahara; Yasutaka Mochizuki; Hiroshi Enaida; Yuji Oshima; Akifumi Ueno; Yasuaki Hata; Hiroki Yoshida; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.